These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Omaveloxolone attenuates squamous cell carcinoma growth and disease severity in an Epidermolysis Bullosa mouse model. Cohen-Nowak AJ; Cohen AJ; Correia ED; Portocarrero CP; South AP; Nikbakht N Exp Dermatol; 2022 Jul; 31(7):1083-1088. PubMed ID: 35285087 [TBL] [Abstract][Full Text] [Related]
13. Cetuximab therapy of metastasizing cutaneous squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa. Arnold AW; Bruckner-Tuderman L; Zuger C; Itin PH Dermatology; 2009; 219(1):80-3. PubMed ID: 19439919 [TBL] [Abstract][Full Text] [Related]
14. Multidisciplinary care for patients with epidermolysis bullosa from birth to adolescence: experience of one Italian reference center. Retrosi C; Diociaiuti A; De Ranieri C; Corbeddu M; Carnevale C; Giancristoforo S; Marchili MR; Salvatori G; Atti MLCD; El Hachem M; Raponi M Ital J Pediatr; 2022 Apr; 48(1):58. PubMed ID: 35414096 [TBL] [Abstract][Full Text] [Related]